Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
118.7 USD | -0.82% | +1.40% | +22.24% |
Jun. 03 | Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to S&P 1000 | CI |
Jun. 03 | Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to S&P 400 - Biotechnology | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.24% | 11.32B | |
+16.85% | 123B | |
+13.06% | 107B | |
-6.22% | 24.01B | |
+1.51% | 22.59B | |
-10.09% | 18.16B | |
-40.52% | 16.84B | |
-12.31% | 16.23B | |
+1.73% | 13.43B | |
+84.70% | 9.19B |
- Stock Market
- Equities
- SRPT Stock
- News Sarepta Therapeutics, Inc.
- Wedbush Starts Sarepta Therapeutics With Outperform Rating, $224 PT; Says Dominance in Duchenne Muscular Dystrophy Presents Notable Commercial Hurdle to Gene Therapy Competitors